Clin2
NCT07423481Likely a fitNot yet recruiting

Weight changes on Wegovy in severe obesity

Obesity & Overweight

Part of Hormones & metabolism clinical trials.

This study is looking at weight changes and factors that affect weight loss in people with severe or complicated obesity who have already started taking Wegovy. Researchers hope to learn what helps predict success with this medication.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have taken Wegovy (semaglutide) at least twice through an early access program.
  • You agree to let the researchers use your medical data for this study.
  • You can fill out a questionnaire online (via the internet).
  • You are not a minor or under legal guardianship or conservatorship.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07728383Recruiting· Phase 4
Obesity treatment study using tongue-applied semaglutide

This trial tests a new way to deliver semaglutide through a strip placed on the tongue for weight loss in adults with obesity. It may help you lose weight without a needle.

Minneapolis, Minnesota
NCT07055607Enrolling by invitation
Real-world study of Wegovy for weight management

This study observes how Wegovy works in everyday medical practice for people who are starting it for the first time. It will help doctors learn more about its real-life benefits and safety.

Barcelona
NCT05872022Enrolling by invitation
Safety study of Wegovy exposure during pregnancy

This study tracks the safety of taking Wegovy during pregnancy. Researchers want to understand potential risks and outcomes when people are exposed to Wegovy in early or any stage of pregnancy.

Princeton, New Jersey
NCT07280221Enrolling by invitation
Wegovy real-world weight loss study in Korea

This study tracks how well Wegovy (a once-weekly injection for weight loss) works for people in Korea who are just starting the medication. It helps doctors understand real-world results outside of a research clinic.

Daejeon
NCT06738979Not yet recruiting· Phase 3
Comparing semaglutide injection to Wegovy® for weight loss

This study tests a new injectable medication (semaglutide) compared to the approved drug Wegovy® for weight loss in people with obesity. It may help you lose weight if you have struggled to keep weight off with diet alone.

Hefei, Anhui
NCT05503927Enrolling by invitation
Study of Wegovy safety during pregnancy

This study looks at health outcomes for pregnant women and their babies after taking Wegovy or other weight-loss medicines. It may help understand if these medicines are safe during pregnancy.

Ann Arbor, Michigan

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.